Probing stemness and neural commitment in human amniotic fluid cells
- PMID: 20221716
- DOI: 10.1007/s12015-010-9116-7
Probing stemness and neural commitment in human amniotic fluid cells
Abstract
Recently, human amniotic fluid (AF) cells have attracted a great deal of attention as an alternative cell source for transplantation and tissue engineering. AF contains a variety of cell types derived from fetal tissues, of which a small percentage is believed to represent stem cell sub-population(s). In contrast to human embryonic stem (ES) cells, AF cells are not subject to extensive legal or ethical considerations; nor are they limited by lineage commitment characteristic of adult stem cells. However, to become therapeutically valuable, better protocols for the isolation of AF stem cell sub-populations need to be developed. This study was designed to examine the molecular components involved in self-renewal, neural commitment and differentiation of AF cells obtained at different gestational ages. Our results showed that, although morphologically heterogeneous, AF cells derived from early gestational periods ubiquitously expressed KERATIN 8 (K8), suggesting that the majority of these cells may have an epithelial origin. In addition, AF cells expressed various components of NOTCH signaling (ligands, receptors and target genes), a pathway involved in stem cell maintenance, determination and differentiation. A sub-population of K8 positive cells (<10%) co-expressed NESTIN, a marker detected in the neuroepithelium, neural stem cells and neural progenitors. Throughout the gestational periods, a much smaller AF cell sub-population (<1%) expressed pluripotency markers, OCT4a, NANOG and SOX2, from which SOX2 positive AF cells could be isolated through single cell cloning. The SOX2 expressing AF clones showed the capacity to give rise to a neuron-like phenotype in culture, expressing neuronal markers such as MAP2, NFL and NSE. Taken together, our findings demonstrated the presence of fetal cells with stem cell characteristics in the amniotic fluid, highlighting the need for further research on their biology and clinical applications.
Similar articles
-
Long-term cultivation of human amniotic fluid stem cells: The impact on proliferative capacity and differentiation potential.J Cell Biochem. 2020 Jul;121(7):3491-3501. doi: 10.1002/jcb.29623. Epub 2020 Jan 3. J Cell Biochem. 2020. PMID: 31898359
-
Third trimester amniotic fluid cells with the capacity to develop neural phenotypes and with heterogeneity among sub-populations.Restor Neurol Neurosci. 2012;30(1):55-68. doi: 10.3233/RNN-2011-0620. Restor Neurol Neurosci. 2012. PMID: 22377907
-
New simple and rapid method for purification of mesenchymal stem cells from the human umbilical cord Wharton jelly.Tissue Eng Part A. 2011 Nov;17(21-22):2651-61. doi: 10.1089/ten.TEA.2010.0587. Epub 2011 Sep 6. Tissue Eng Part A. 2011. PMID: 21679124
-
Concise Review: Amniotic Fluid Stem Cells: The Known, the Unknown, and Potential Regenerative Medicine Applications.Stem Cells. 2017 Jul;35(7):1663-1673. doi: 10.1002/stem.2553. Stem Cells. 2017. PMID: 28009066 Review.
-
Isolation and in vitro characterization of bovine amniotic fluid derived stem cells at different trimesters of pregnancy.Stem Cell Rev Rep. 2014 Oct;10(5):712-24. doi: 10.1007/s12015-014-9525-0. Stem Cell Rev Rep. 2014. PMID: 24906426 Review.
Cited by
-
Amniotic fluid-derived stem cells for cardiovascular tissue engineering applications.Tissue Eng Part B Rev. 2013 Aug;19(4):368-79. doi: 10.1089/ten.TEB.2012.0561. Epub 2013 Mar 14. Tissue Eng Part B Rev. 2013. PMID: 23350771 Free PMC article. Review.
-
Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats.PLoS One. 2012;7(8):e43779. doi: 10.1371/journal.pone.0043779. Epub 2012 Aug 17. PLoS One. 2012. PMID: 22912905 Free PMC article.
-
Novel RBPJ transcripts identified in human amniotic fluid cells.Stem Cell Rev Rep. 2010 Dec;6(4):677-84. doi: 10.1007/s12015-010-9162-1. Stem Cell Rev Rep. 2010. PMID: 20574714
-
Efficient direct reprogramming of mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression.Cell. 2012 Oct 26;151(3):559-75. doi: 10.1016/j.cell.2012.09.032. Epub 2012 Oct 18. Cell. 2012. PMID: 23084400 Free PMC article.
-
Genetic reprogramming of human amniotic cells with episomal vectors: neural rosettes as sentinels in candidate selection for validation assays.PeerJ. 2014 Nov 18;2:e668. doi: 10.7717/peerj.668. eCollection 2014. PeerJ. 2014. PMID: 25426336 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials